Ibere Pharmaceuticals Stock (NYSE:IBER)
Previous Close
$10.20
52W Range
$9.75 - $10.75
50D Avg
$10.14
200D Avg
$9.95
Market Cap
$175.60M
Avg Vol (3M)
$84.33K
Beta
-
Div Yield
-
IBER Company Profile
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.